Shuji Arita

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai et al. · Cancer Chemotherapy and Pharmacology · 2013 · 101 citations

Medicine, Oncology, Pharmacology +6

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

Kenji Tamura, Jun Hashimoto, Yuko Tanabe et al. · Cancer Chemotherapy and Pharmacology · 2016 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

Akitaka Makiyama, Kohei Arimizu, Gen Hirano et al. · Gastric Cancer · 2017 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

B cell activation regulates exosomal HLA production

Shuji Arita, Eishi Baba, Yoshihiro Shibata et al. · European Journal of Immunology · 2008 · 50 citations

Life Sciences, Cell Biology, Immunology +17

Human STEAP3 maintains tumor growth under hypoferric condition

Taichi Isobe, Eishi Baba, Shuji Arita et al. · Experimental Cell Research · 2011 · 46 citations

Medicine, Cancer Biology, Molecular Biology +8